Literature DB >> 2724264

Early detection of lung function abnormalities in infants with cystic fibrosis.

R Kraemer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2724264      PMCID： PMC1291915     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  30 in total

1.  Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

2.  Antimicrobial therapy of Pseudomonas pulmonary exacerbations in cystic fibrosis. A prospective evaluation of netilmicin plus azlocillin versus netilmicin plus ticarcillin.

Authors:  U B Schaad; D Desgrandchamps; R Kraemer
Journal:  Acta Paediatr Scand       Date:  1986-01

3.  Dose-response relationships and time course of the response to systemic beta adrenoreceptor agonists in infants with bronchopulmonary disease.

Authors:  R Kraemer; P Birrer; M H Schöni
Journal:  Thorax       Date:  1988-10       Impact factor: 9.139

4.  Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants.

Authors:  C O'Callaghan; A D Milner; A Swarbrick
Journal:  Lancet       Date:  1986 Dec 20-27       Impact factor: 79.321

5.  Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans.

Authors:  D J Ding; J G Martin; P T Macklem
Journal:  J Appl Physiol (1985)       Date:  1987-03

6.  Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.

Authors:  U B Schaad; J Wedgwood-Krucko; S Suter; R Kraemer
Journal:  J Pediatr       Date:  1987-10       Impact factor: 4.406

7.  Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

8.  Physiologic effects of terbutaline on pulmonary function of infants with bronchopulmonary dysplasia.

Authors:  R Sosulski; S Abbasi; V K Bhutani; W W Fox
Journal:  Pediatr Pulmonol       Date:  1986 Sep-Oct

9.  Short-time response characteristics of salbutamol in infants with broncho-pulmonary diseases.

Authors:  R Kraemer; P Birrer; F H Sennhauser; M H Schöni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Effect of compression pressure on forced expiratory flow in infants.

Authors:  P N Le Souëf; D M Hughes; L I Landau
Journal:  J Appl Physiol (1985)       Date:  1986-11
View more
  3 in total

Review 1.  Monitoring early inflammation in CF. Infant pulmonary function testing.

Authors:  Jack K Sharp
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

2.  Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis.

Authors:  Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso
Journal:  J Pediatr       Date:  2009-12       Impact factor: 4.406

3.  Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis.

Authors:  Richard Kraemer; David N Baldwin; Roland A Ammann; Urs Frey; Sabina Gallati
Journal:  Respir Res       Date:  2006-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.